EPT Disclosure

22 Jun 2006 11:11

Morgan Stanley Securities Ld(EPT)22 June 2006 DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY (Rule 38.5(a) of the Takeover Code) 1. KEY INFORMATION Name of exempt principal trader Morgan Stanley Securities LimitedCompany dealt in Cambridge Antibody Technology Group Plc Class of relevant security to which the Ordinary Sharesdealings being disclosed relate (Note 1) Date of dealing 21 June 2006 2. DEALINGS (Note 2) (a) Purchases and sales Total number of securities purchased Highest price paid (Note 3) GBP Lowest price paid (Note 3) GBP 121,466 13.13 13.09 Total number of securities sold Highest price received (Note 3) GBP Lowest price received (Note 3) GBP 9,751 13.13 13.11 b) Derivatives transactions (other than options) Product name, Long/short (Note 4) Number of securities (Note 5) Price per unit (Note 3) GBP e.g. CFDCFD LONG 121,466 13.14CFD SHORT 9,751 13.10 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relatingto the voting rights of any relevant securities under any option referred to on this form or relating to the votingrights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form isreferenced. If none, this should be stated. Date of disclosure 22 June 2006 Contact name Mandeep Bhandal Telephone number 020 7677 5468 Name of offeree/offeror with which connected Cambridge Antibody Technology Group Plc Nature of connection (Note 6) Advisor Notes The Notes on Form 38.5(a) can be viewed on the Takeover Panel's website atwww.thetakeoverpanel.org.uk This information is provided by RNS The company news service from the London Stock Exchange